Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue Vaccine
Clinical trial NCT01943825 · COMPLETED
Trial details
- NCT number
- NCT01943825
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-05
- Primary completion
- 2015-11-25
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.